Ximelagatran

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Ximelagatran are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Ximelagatran?

The molecule Ximelagatran presents a molecular formula of C24H35N5O5 and its IUPAC name is ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate.

Ximelagatran (INN) is a direct thrombin inhibitor. It was developed by AstraZeneca and was in Phase III clinical trials for the prevention of stroke and systemic embolism in patients with atrial fibrillation when AstraZeneca discontinued its development in 2006..

Ximelagatran is a synthetic, small molecule that is structurally similar to melagatran, the active metabolite of the direct thrombin inhibitor hirudin. Ximelagatran is a prodrug that is rapidly converted in vivo to its active metabolite, melagatran..

Ximelagatran was being developed for the prevention of stroke and systemic embolism in patients with atrial fibrillation. The efficacy of ximelagatran in this indication was demonstrated in the SPORTIF III and V clinical trials..

AstraZeneca discontinued the development of ximelagatran in 2006 due to concerns about liver toxicity. The liver toxicity was seen at doses of ximelagatran that were associated with an increased risk of bleeding..

Ximelagatran was not approved by the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA)..

AstraZeneca has since developed another direct thrombin inhibitor, dabigatran, which is approved in the US and Europe for the prevention of stroke and systemic embolism in patients with atrial fibrillation..

3D structure

Cartesian coordinates

Geometry of Ximelagatran in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Ximelagatran ZXIBCJHYVWYIKI-PZJWPPBQSA-N chemical compound 2D structure molecule svg
Ximelagatran

 

Molecule descriptors

 
IUPAC nameethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate
InChI codeInChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1
InChI KeyZXIBCJHYVWYIKI-PZJWPPBQSA-N
SMILESCCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N\O)cc1)C1CCCCC1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • 1243838-77-8
  • 192939-46-1
  • 49HFB70472
  • A880297
  • CS-0002822
  • D01981
  • DB04898
  • DSSTox_CID_29001
  • DSSTox_GSID_49075
  • DSSTox_RID_83266
  • Ethyl (((1R)-1-cyclohexyl-2-((2S)-2-((4-(hydroxycarbamimidoyl)benzyl)carbamoyl)azetidin-1-yl-2-oxoethyl)amino)acetate
  • Exanta
  • Exanta (proposed)
  • Exarta
  • Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-, ethyl ester
  • Glycine, N-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester
  • Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-((hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ester ester
  • Glycine, N-((1R)-1-cyclohexyl-2-((2S)-2-((((4-(hydroxyamino)iminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-2-oxoethyl)-, ethyl ester
  • H 376 95
  • H 376-95
  • H 376/95
  • H 37695
  • H-376/95
  • HY-10787
  • J-012490
  • NCGC00183598-01
  • NCGC00183598-02
  • Ximelagatran
  • Ximelagatran (JAN/USAN/INN)
  • ethyl ((R)-1-cyclohexyl-2-((S)-2-((4-((Z)-N'-hydroxycarbamimidoyl)benzyl)carbamoyl)azetidin-1-yl)-2-oxoethyl)glycinate
  • ethyl ({(1R)-1-cyclohexyl-2-[(2S)-2-({[4-(N-hydroxycarbamimidoyl)phenyl]methyl}carbamoyl)azetidin-1-yl]-2-oxoethyl}amino)acetate
  • ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(N'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate
  • ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate
  • ethyl 2-{[(1R)-1-cyclohexyl-2-[(2S)-2-({[4-(N-hydroxycarbamimidoyl)phenyl]methyl}carbamoyl)azetidin-1-yl]-2-oxoethyl]amino}acetate
  • ethyl 2-{[(1R)-1-cyclohexyl-2-[(2S)-2-[({4-[(Z)-N'-hydroxycarbamimidoyl]phenyl}methyl)carbamoyl]azetidin-1-yl]-2-oxoethyl]amino}acetate
  • ethyl N-{(1R)-1-cyclohexyl-2-[(2S)-2-{[4-(N'-hydroxycarbamimidoyl)benzyl]carbamoyl}azetidin-1-yl]-2-oxoethyl}glycinate
  • glycine, N-((1R)1-cyclohexyl-2-((2S)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester
  • xi-melagatran
  • ximelagatran (hydroxylamine form)
  • ximelagatran (oxime form)
  • ximelagatranum

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC12504524
  • CAS-192939-46-1
  • UNII-49HFB70472
  • DTXSID5049075
  • CHEBI:136702
  • Tox21_113633
  • SCHEMBL4845
  • SCHEMBL4846
  • SCHEMBL8039753

Physico-Chemical properties

IUPAC nameethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate
Molecular formulaC24H35N5O5
Molecular weight473.565
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity130.28
LogP2.5
Topological polar surface area146.4

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.